Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 11, 2009
Patent Application Number
11750613
Date Filed
May 18, 2007
Patent Citations Received
Patent Primary Examiner
Patent abstract
Formulations of an interleukin-1 (IL-1) antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the IL-1 antagonist is an IL-1 trap composed of a dimer of two fusion protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 10.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
